Cancer metastasis accounts for the high mortality of many types of cancer. Owing to the unique advantages of high specificity and minimal invasiveness, photothermal therapy (PTT) has been evidenced with great potential in treating cancer metastasis. In this review, we outline the current approaches of PTT with respect to its application in treating metastatic cancer. PTT can be used alone, guided with multimodal imaging, or combined with the current available therapies for effective treatment of cancer metastasis. Numerous types of photothermal nanotherapeutics (PTN) have been developed with encouraging therapeutic efficacy on metastatic cancer in many preclinical animal experiments. We summarize the design and performance of various PTN in PTT alone and their combinational therapy. We also point out the lacking area and the most promising approaches in this challenging field. In conclusion, PTT or their combinational therapy can provide an essential promising therapeutic modality against cancer metastasis.

/pdf/current-approaches-of-photothermal-therapy-in-treating-4ua7merhs2.pdf

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics.

The field of 3D printing is continuing its rapid development in both academic and industrial research environments. The development of 3D printing technologies has opened new implementations in rapid prototyping, tooling, dentistry, microfluidics, biomedical devices, tissue engineering, drug delivery, etc. Among different 3D printing techniques, photopolymerization-based process (such as stereolithography and digital light processing) offers flexibility over the final properties of the 3D printed materials (such as optical, chemical, and mechanical properties) using versatile polymer chemistry. The strategy behind the 3D photopolymerization is based on using monomers/oligomers in liquid state (in the presence of photoinitiators) that can be photopolymerized (via radical or cationic mechanism) upon exposure to light source of different wavelengths (depending on the photoinitiator system). An overview of recent evolutions in the field of photopolymerization-based 3D printing and highlights of novel 3D print...

Photopolymerization in 3D Printing

The near-infrared (NIR) region of the spectrum is called the "therapeutic window" because NIR light can penetrate deeply into tissue. Therefore, NIR-sensitive materials are attractive for biomedical applications. Recently, upconverting nanoparticles (UCNPs) were used to construct NIR-sensitive materials. UCNPs convert NIR light to UV or visible light, which can trigger photoreactions of photosensitive materials. Here, how to use UCNPs to construct NIR-sensitive materials is introduced, applications of NIR-sensitive materials with a focus on biomedical applications are highlighted, and the associated challenges are discussed.

Near‐Infrared‐Sensitive Materials Based on Upconverting Nanoparticles

Traumatic brain injury (TBI) is a growing health concern effecting civilians and military personnel. Research has yielded a better understanding of the pathophysiology of TBI, but effective treatments have not been forthcoming. Near-infrared light (NIR) has shown promise in animal models of both TBI and stroke. Yet, it remains unclear if sufficient photonic energy can be delivered to the human brain to yield a beneficial effect. This paper reviews the pathophysiology of TBI and elaborates the physiological effects of NIR in the context of this pathophysiology. Pertinent aspects of the physical properties of NIR, particularly in regards to its interactions with tissue, provide the background for understanding this critical issue of light penetration through tissue. Our recent tissue studies demonstrate no penetration of low level NIR energy through 2 mm of skin or 3 cm of skull and brain. However, at 10-15 W, 0.45%-2.90% of 810 nm light penetrated 3 cm of tissue. A 15 W 810 nm device (continuous or non-pulsed) NIR delivered 2.9% of the surface power density. Pulsing at 10 Hz reduced the dose of light delivered to the surface by 50%, but 2.4% of the surface energy reached the depth of 3 cm. Approximately 1.22% of the energy of 980 nm light at 10-15 W penetrated to 3 cm. These data are reviewed in the context of the literature on low-power NIR penetration, wherein less than half of 1% of the surface energy could reach a depth of 1 cm. NIR in the power range of 10-15 W at 810 and 980 nm can provide fluence within the range shown to be biologically beneficial at 3 cm depth. A companion paper reviews the clinical data on the treatment of patients with chronic TBI in the context of the current literature.

https://www.dovepress.com/getfile.php?fileID=26632

Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?

The deployment of hyperthermia-based treatments for cancer therapy has captured the attention of different researchers worldwide. In particular, the application of light-responsive nanomaterials to mediate hyperthermia has revealed promising results in several pre-clinical assays. Unlike conventional therapies, these nanostructures can display a preferential tumor accumulation and thus mediate, upon irradiation with near-infrared light, a selective hyperthermic effect with temporal resolution. Different types of nanomaterials such as those based on gold, carbon, copper, molybdenum, tungsten, iron, palladium and conjugated polymers have been used for this photothermal modality. This progress report summarizes the different strategies that have been applied so far for increasing the efficacy of the photothermal therapeutic effect mediated by nanomaterials, namely those that improve the accumulation of nanomaterials in tumors (e.g. by changing the corona composition or through the functionalization with targeting ligands), increase nanomaterials' intrinsic capacity to generate photoinduced heat (e.g. by synthesizing new nanomaterials or assembling nanostructures) or by optimizing the parameters related to the laser light used in the irradiation process (e.g. by modulating the radiation wavelength). Overall, the development of new strategies or the optimization and combination of the existing ones will surely give a major contribution for the application of nanomaterials in cancer PTT.

Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials.

Objective: The purpose of this study was to compare the penetration of 808 and 980 nm laser light through bovine tissue samples 18–95 mm thick. Background data: Low-level laser therapy (LLLT) is frequently used to treat musculoskeletal pathologies. Some of the therapeutic targets are several centimeters deep. Methods: Laser light at 808 and 980 nm (1 W/cm2) was projected through bovine tissue samples ranging in thickness from 18 to 95 mm. Power density measurements were taken for each wavelength at the various depths. Results: For 808 nm, 1 mW/cm2 was achieved at 3.4 cm, but for 980 nm, 1 mW/cm2 was achieved at only 2.2 cm depth of tissue. Conclusions: It was determined that 808 nm of light penetrates as much as 54% deeper than 980 nm light in bovine tissue.

/pdf/penetration-of-laser-light-at-808-and-980-nm-in-bovine-noq4g8hsma.pdf

Penetration of laser light at 808 and 980 nm in bovine tissue samples.

Low level laser therapy apparatus for treatment of various conditions is described. In one embodiment, the apparatus includes a hand-held laser probe coupled to a control unit. The probe includes a probe head in which a laser diode(s) is mounted, emitting energy having a wavelength of 670 nm, 830 nm, 867 nm, 904 nm or 980 nm and configured to emit laser energy at a mean output power from 1 mW to 600 mW. The apparatus includes a heat-sensitive power management system allowing for continued use at high power output and audible tone to signify each joule of laser energy output. In an alternative embodiment, the apparatus includes a magnetic card reading device used in conjunction with the control unit to create single or double blinded studies with the device.

Donald E. Hudson

Papers

Penetration of laser light at 808 and 980 nm in bovine tissue samples.

Luminex® laser therapy system